Rosellini Scientific LLC is categorized under Medical Research in Dallas, TX and active since 2005.
Rosellini Scientific LLC was established in 2005, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact William M Rosellini at the company’s headquarters by writing to 13739 Sprucewood Circle, Dallas, Texas TX 75240 or by phoning (800) 730-2437. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rosellini Scientific LLC |
| Contact Person: | William M Rosellini |
| Address: | 13739 Sprucewood Circle, Dallas, Texas 75240 |
| Phone Number: | (800) 730-2437 |
| Website Address: | roselliniscientific.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2005 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Rosellini Scientific LLC was started in 2005 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact William M Rosellini for inquiries that concern Rosellini Scientific LLC by calling the company number (800) 730-2437, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Rosellini Scientific LLC can be found at the coordinates 32.936607,-96.777701 as well as the street address 13739 Sprucewood Circle in Dallas, Texas 75240.
For its online presence, you may visit Rosellini Scientific LLC’s website at roselliniscientific.com and engage with its social media outlets through on Twitter and on Facebook.